Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M S Orr

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Leukemia|April 18, 2002
Large-scale gene expression analysis in molecular target discoveryM S Orr, U Scherf
Journal of the National Cancer Institute|June 22, 2000
Effects of c-erbB2 overexpression on the drug sensitivities of normal human mammary epithelial cellsM S Orr, P M O'Connor, K W Kohn
Biochimica Et Biophysica Acta|June 9, 1995
Transcriptional down-regulation of c-myc expression in the MCF-7 breast tumor cell line by the topoisomerase II inhibitor, VM-26M S Orr, F A Fornari, J K Randolph, et al.
Clinical Pharmacology and Therapeutics|January 30, 2007
The experience with voluntary genomic data submissions at the FDA and a vision for the future of the voluntary data submission programM S Orr, F Goodsaid, S Amur, et al.
The Journal of Biological Chemistry|March 28, 1998
An important role for the retinoblastoma protein in staurosporine-induced G1 arrest in murine embryonic fibroblastsM S Orr, W Reinhold, L Yu, et al.
International Journal of Radiation Biology|February 1, 1996
Radiosensitization of HL-60 human leukaemia cells by bryostatin-1 in the absence of increased DNA fragmentation or apoptotic cell deathN C Watson, W D Jarvis, M S Orr, et al.
Cancer Chemotherapy and Pharmacology|April 2, 1998
Induction of DNA damage, inhibition of DNA synthesis and suppression of c-myc expression by the anthracycline analog, idarubicin (4-demethoxy-daunorubicin) in the MCF-7 breast tumor cell lineD A Gewirtz, J K Randolph, J Chawla, et al.
Biochemical Pharmacology|August 27, 1998
Induction of DNA damage, inhibition of DNA synthesis, and suppression of c-myc expression by the topoisomerase I inhibitor, camptothecin, in MCF-7 human breast tumor cellsP T Jain, F A Fornari, J K Randolph, et al.
Molecular Pharmacology|September 1, 1997
Ionizing radiation and teniposide increase p21(waf1/cip1) and promote Rb dephosphorylation but fail to suppress E2F activity in MCF-7 breast tumor cellsM S Orr, N C Watson, S Sundaram, et al.
Biochemical Pharmacology|January 20, 1994
Influence of amsacrine (m-AMSA) on bulk and gene-specific DNA damage and c-myc expression in MCF-7 breast tumor cellsR T Bunch, L F Povirk, M S Orr, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Leukemia|April 18, 2002
Large-scale gene expression analysis in molecular target discoveryM S Orr, U Scherf
Journal of the National Cancer Institute|June 22, 2000
Effects of c-erbB2 overexpression on the drug sensitivities of normal human mammary epithelial cellsM S Orr, P M O'Connor, K W Kohn
Biochimica Et Biophysica Acta|June 9, 1995
Transcriptional down-regulation of c-myc expression in the MCF-7 breast tumor cell line by the topoisomerase II inhibitor, VM-26M S Orr, F A Fornari, J K Randolph, et al.
Clinical Pharmacology and Therapeutics|January 30, 2007
The experience with voluntary genomic data submissions at the FDA and a vision for the future of the voluntary data submission programM S Orr, F Goodsaid, S Amur, et al.
The Journal of Biological Chemistry|March 28, 1998
An important role for the retinoblastoma protein in staurosporine-induced G1 arrest in murine embryonic fibroblastsM S Orr, W Reinhold, L Yu, et al.
International Journal of Radiation Biology|February 1, 1996
Radiosensitization of HL-60 human leukaemia cells by bryostatin-1 in the absence of increased DNA fragmentation or apoptotic cell deathN C Watson, W D Jarvis, M S Orr, et al.
Cancer Chemotherapy and Pharmacology|April 2, 1998
Induction of DNA damage, inhibition of DNA synthesis and suppression of c-myc expression by the anthracycline analog, idarubicin (4-demethoxy-daunorubicin) in the MCF-7 breast tumor cell lineD A Gewirtz, J K Randolph, J Chawla, et al.
Biochemical Pharmacology|August 27, 1998
Induction of DNA damage, inhibition of DNA synthesis, and suppression of c-myc expression by the topoisomerase I inhibitor, camptothecin, in MCF-7 human breast tumor cellsP T Jain, F A Fornari, J K Randolph, et al.
Molecular Pharmacology|September 1, 1997
Ionizing radiation and teniposide increase p21(waf1/cip1) and promote Rb dephosphorylation but fail to suppress E2F activity in MCF-7 breast tumor cellsM S Orr, N C Watson, S Sundaram, et al.
Biochemical Pharmacology|January 20, 1994
Influence of amsacrine (m-AMSA) on bulk and gene-specific DNA damage and c-myc expression in MCF-7 breast tumor cellsR T Bunch, L F Povirk, M S Orr, et al.
Pageof 2